Jak Knowles
Chief Executive Officer at Affini-T Therapeutics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jürgen Eckhardt | M | 57 |
Vesigen, Inc.
 Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA.
Triumvira Immunologics, Inc.
 Triumvira Immunologics, Inc. Pharmaceuticals: MajorHealth Technology Triumvira Immunologics, Inc. develops and manufactures pharmaceutical products. The company was founded by Jonathan Bramson in 2015 and is headquartered in Hamilton, Canada. | 4 years |
| Jian Irish | M | 60 |
Affini-T Therapeutics, Inc.
 Affini-T Therapeutics, Inc. BiotechnologyHealth Technology Affini-T Therapeutics, Inc. is a biotechnology company based in Watertown, MA. Affini-t is focused on developing potentially curative therapies for solid tumor cancers by unlocking the power of T cells and targeting core oncogenic drivers. The company's differentiated cell therapy platform harnesses state-of-the-art engineering and synthetic biology capabilities to optimize T cell functions and rewrite the rules of the solid tumor microenvironment, enabling the potential for sustained clinical outcomes in patients. The company is targeting Kras and other oncogenic and viral driver mutations to open a new and differentiated target space, thereby minimizing the risk of cancer. The company was founded by Jak Knowles and Arjun Goyal, with Jak Knowles serving as the CEO since incorporation. | 3 years |
| Dieter Weinand | M | 63 |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | 9 years |
| Lara Sullivan | M | 51 | 5 years | |
| Norbert Winkeljohann | M | 66 | 6 years | |
| Gregory Russotti | M | 57 | 4 years | |
| Joseph Jimenez | M | 64 | 5 years | |
| Simren Delaney | M | 38 | 4 years | |
| Ertharin Cousin | M | 67 | 5 years | |
| Lucio Iannone | M | 41 |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | 5 years |
| Geeta S. Vemuri | M | - |
Agent Capital LLC
 Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | 7 years |
| Horst Heinz Paul Baier | M | 66 | 4 years | |
| Wolfgang U. Nickl | M | 55 | 6 years | |
| Debra Miller | F | - |
CureDuchenne
 CureDuchenne Financial ConglomeratesFinance CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA. | 21 years |
| Lianna Orlando | M | - |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA. | 5 years |
| Paul Miller | M | - |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA. | 21 years |
| Arjun Goyal | M | - |
Affini-T Therapeutics, Inc.
Affini-T Therapeutics, Inc. BiotechnologyHealth Technology Affini-T Therapeutics, Inc. is a biotechnology company based in Watertown, MA. Affini-t is focused on developing potentially curative therapies for solid tumor cancers by unlocking the power of T cells and targeting core oncogenic drivers. The company's differentiated cell therapy platform harnesses state-of-the-art engineering and synthetic biology capabilities to optimize T cell functions and rewrite the rules of the solid tumor microenvironment, enabling the potential for sustained clinical outcomes in patients. The company is targeting Kras and other oncogenic and viral driver mutations to open a new and differentiated target space, thereby minimizing the risk of cancer. The company was founded by Jak Knowles and Arjun Goyal, with Jak Knowles serving as the CEO since incorporation. | 3 years |
| Kathy Yi | F | 52 |
Affini-T Therapeutics, Inc.
Affini-T Therapeutics, Inc. BiotechnologyHealth Technology Affini-T Therapeutics, Inc. is a biotechnology company based in Watertown, MA. Affini-t is focused on developing potentially curative therapies for solid tumor cancers by unlocking the power of T cells and targeting core oncogenic drivers. The company's differentiated cell therapy platform harnesses state-of-the-art engineering and synthetic biology capabilities to optimize T cell functions and rewrite the rules of the solid tumor microenvironment, enabling the potential for sustained clinical outcomes in patients. The company is targeting Kras and other oncogenic and viral driver mutations to open a new and differentiated target space, thereby minimizing the risk of cancer. The company was founded by Jak Knowles and Arjun Goyal, with Jak Knowles serving as the CEO since incorporation. | - |
| Thomas Liu | M | - |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA. | - |
| Stefan Oelrich | M | 55 | 6 years | |
| TJ Farnsworth | M | - |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA. | - |
| Ron Philip | M | - |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA. | - |
| Jacopo Leonardi | M | 52 |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | 4 years |
| Michael G. Kelly | M | - |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA. | 13 years |
| Philippe Lopes-Fernandes | M | - |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | - |
| Simon Harnest | M | 37 | 3 years | |
| Preston Noon | M | - |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | - |
| Pier Puri | M | - |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA. | - |
| Marla McMillan | F | - |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | - |
| Willard Dere | M | 70 | 3 years | |
| Andrea Sacher | F | 43 | 4 years | |
| Ryan D. Teksten | M | - |
NewLeaf Symbiotics, Inc.
 NewLeaf Symbiotics, Inc. Chemicals: AgriculturalProcess Industries NewLeaf Symbiotics, Inc. develops and commercializes a family of beneficial bacteria. It commercializes Pink Pigmented Facultative Methylotrophs bacteria that improves plant health, promote early growth, and increase crop yield. The company was founded by Stephen Kahn, Thomas R. Laurita and Michael Bielski in 2012 and is headquartered in St. Louis, MO. | 4 years |
| Brandon Tarnow | M | - |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA. | - |
| Robert Parkinson | M | 73 |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | - |
| Drew Hoyer | M | - |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA. | 11 years |
| John Orloff | M | 66 |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | 3 years |
| Timothy Sandel | M | - |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA. | - |
| Nicole Vitullo | F | 66 |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | - |
| Norbert Riedel | M | 66 |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | - |
| Bruce Peacock | M | 72 |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | - |
| Alessandro A. Piol | M | 67 |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA. | - |
| Wayne H. Thompson | M | - |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | - |
| Robert Hombach | M | 58 |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | - |
| Peggy Larson | F | - |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA. | 13 years |
| Christine-Rio Gaxiola | F | - |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA. | - |
| Evonne Sepsis | F | - |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA. | - |
| Jesse Dylan | M | - |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA. | - |
| Kathi Sharpe-Ross | F | - |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA. | - |
| Royston Glasspool | M | 61 |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | 6 years |
| Kevin Dorsey | M | - |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA. | - |
| Sebastián Bernales | M | 48 | 4 years | |
| Karen Harley | F | - |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA. | 13 years |
| Mike Rosen | M | - |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA. | - |
| Ryan williams | M | - |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA. | - |
| Sue Sales | F | - |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA. | 13 years |
| Heather Schuster | F | - |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA. | 12 years |
| Elaine Wu | F | - |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA. | - |
| George W. Blank | M | - |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA. | - |
| Thomas Hoffmann | M | 53 | 5 years | |
| Bijoy Sagar | M | 55 | 4 years | |
| Alan Brooks | M | 58 | 5 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert A. Millman | M | - |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | - |
| Werner Wenning | M | 77 | 54 years | |
| Shaan Gandhi | M | 38 | 2 years | |
| Aparna Sinha | M | - |
Stanford University
| - |
| Hartmut Klusik | M | 67 | 3 years | |
| John Kryzwicki | M | - |
Stanford University
| 7 years |
| Nafis Jamal | M | - |
Stanford University
| 7 years |
| Hugh Browne | M | - |
Stanford University
| 2 years |
| Iveshu Bhatia | M | - |
Stanford University
| 1 years |
| Joel Dudley | M | - |
Stanford University
| 4 years |
| Jonathan Hsu | M | - |
Stanford University
| 5 years |
| Justin Wilson | M | 42 |
Stanford University
| 5 years |
| Wesley Lim | M | - |
Stanford University
| 4 years |
| Dustin Espersen | M | - |
Stanford University
| 5 years |
| Jung-il Choi | M | - |
Stanford University
| 6 years |
| William Chan | M | - |
Stanford University
| 3 years |
| Kenneth King | M | 38 |
Stanford University
| 5 years |
| Ibrahim Almojel | M | - |
Stanford University
| 6 years |
| Nabeel Hasnain | M | - |
Stanford University
| 4 years |
| Argyrios Zymnis | M | - |
Stanford University
| 5 years |
| Balaji S. Srinivasan | M | - |
Stanford University
| 6 years |
| Michael Paulus | M | - |
Stanford University
| 5 years |
| John Melas-Kyriazi | M | - |
Stanford University
| 4 years |
| Manu Lakkur | M | - |
Stanford University
| 5 years |
| Mike C. Diem | M | 54 | 4 years | |
| Jenny P. Chen | F | - |
Stanford University
| 6 years |
| Ali Jamal | M | - |
Stanford University
| 5 years |
| Renata Streit Quintini | F | - |
Stanford University
| 4 years |
| Rapp Alyssa | F | 45 |
Stanford University
| 2 years |
| David Topham | M | - |
Stanford University
| 4 years |
| Mike Jackson | M | - |
Stanford University
| 5 years |
| Mada Seghete | F | - |
Stanford University
| 8 years |
| Johannes M. Dietsch | M | 62 | 16 years | |
| Robin Tsai | M | - |
Stanford University
| 7 years |
| Martin Casado | M | - |
Stanford University
| 6 years |
| Nathan Evans | M | - |
Stanford University
| 6 years |
| Alex W. Bergman | M | - |
Stanford University
| 2 years |
| Kunal Ghosh | M | - |
Stanford University
| 5 years |
| Petr Johanes | M | - |
Stanford University
| 12 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 89 | 89.00% |
| Germany | 12 | 12.00% |
| Canada | 1 | 1.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jak Knowles
- Personal Network